Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh · Delayed Price · Currency is BDT

57.30

0.00 (0.00%)

At close: Mar 24, 2026

Revenue by Segment

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Human Health	8.47B	6.62B	5.39B	4.55B	3.42B
Human Health Growth	27.92%	22.92%	18.36%	33.25%	14.86%
Veterinary	1.64B	1.40B	1.27B	1.03B	711.69M
Veterinary Growth	16.79%	10.60%	23.30%	44.72%	10.15%
Total	10.11B	8.03B	6.66B	5.58B	4.13B
Total Growth	25.97%	20.57%	19.27%	35.23%	14.02%

Revenue by Geography

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Bangladesh	9.73B	7.78B	6.42B	5.41B	3.89B
Bangladesh Growth	25.20%	21.03%	18.83%	39.05%	12.07%
Export	377.98M	252.74M	234.03M	176.40M	240.26M
Export Growth	49.56%	7.99%	32.67%	-26.58%	58.74%
Unallocated	-1.27B	-1.13B	-952.15M	-823.79M	-521.65M
Total	8.84B	6.90B	5.71B	4.76B	3.61B
Total Growth	28.19%	20.89%	19.91%	31.95%	14.53%

Source: S&P Global Market Intelligence.